Breaking News Headlines Today

News about Eli Lilly

Stay current with all the latest and breaking news about Eli Lilly, compare headlines and perspectives between news sources on stories happening today. In total, 467 stories have been published about Eli Lilly which Ground News has aggregated in the past 3 months.

Covered Most By

Local News Publishers

Suggest a source

Looking for a source we don't already have? Suggest one here.

Top Eli Lilly News

Virginia Politics · Virginia

Eli Lilly to invest $5 billion in new Virginia plant as pharma braces for tariffs

58% Center coverage: 17 sources

See the Story

Donald Trump · United States

UK's GSK Announces $30 Billion U.S. Pharma Investment Amid Trump State Visit

54% Center coverage: 13 sources

British pharmaceutical giant GSK committed to investing at least $30 billion in U.S. research and developing and manufacturing over the next five years.See the Story

Jim Cramer · Indianapolis

Eli Lilly’s obesity pill outperforms Novo Nordisk’s oral drug in head-to-head diabetes trial

100% Center coverage: 2 sources

Eli Lilly said orforglipron was better at lowering blood sugar levels than Novo Nordisk's oral semaglutide, and helped patients lose more weight.See the Story

Jim Cramer says Eli Lilly's obesity pill could be more of a 'lifetime drug' than shots

100% Center coverage: 1 sources

"Persistence is the enemy of these [GLP-1 drugs] right now," CNBC's Jim Cramer said Wednesday.Jim Cramer · United States See the Story

Novo Nordisk Stock Is a Better Obesity Play Than Eli Lilly, Berenberg Says

The Entire Business World on a Single Page with the Web's Most Comprehensive One-Stop Finance News Hub.Eli Lilly Read Article

Eli Lilly’s obesity pill outperforms Novo Nordisk’s oral drug in head-to-head diabetes trial

100% Center coverage: 2 sources

Eli Lilly said orforglipron was better at lowering blood sugar levels than Novo Nordisk's oral semaglutide, and helped patients lose more weight.Jim Cramer · Indianapolis See the Story

Berenberg Bank Reiterates "Hold" Rating for Eli Lilly and Company (NYSE:LLY)

100% Center coverage: 1 sources

Berenberg Bank reiterated a "hold" rating and set a $830.00 price objective (down previously from $970.00) on shares of Eli Lilly and Company in a research note on Wednesday.Eli Lilly Read Article

Alchemab Therapeutics initiates Phase 1 clinical trial of ATLX-1282 and announces Series A financing extension

– Follows successful completion of pre-clinical activities by Alchemab as part of earlier licensing deal with Eli Lilly and Company for ATLX-1282 – Financing included participation from Eli Lilly and Company and Ono Venture Investment alongside significant support from world-class existing investors CAMBRIDGE, England, Sept. 9, 2025 /PRNewswire/ — Alchemab Therapeutics (Alchemab), a biopharmaceutical company which identifies and develops nat…Eli Lilly · England Read Article

Lilly Weakens on Data Reveal for Oral Obesity Candidate

100% Center coverage: 2 sources

Eli Lilly is preparing to file for approval of its oral weight-loss drug orforglipron before year-end, but not all are convinced by the data.Eli Lilly See the Story

MassMutual Private Wealth & Trust FSB Purchases 376 Shares of Eli Lilly and Company $LLY

MassMutual Private Wealth & Trust FSB boosted its stake in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 10.4% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 3,994 shares of the company’s stock after purchasing an additional 376 […]Eli Lilly · Indianapolis Read Article

After Oprah Winfrey Special: Novo Nordisk Receives Us Warning

Both Novo Nordisk and Eli Lilly were issued warnings by US health authorities on Tuesday for using "false or misleading" marketing in connection with an Oprah Winfrey special from March 2024.Oprah Winfrey · United States Read Article

Eli Lilly to invest $5 billion in new Virginia plant as pharma braces for tariffs

58% Center coverage: 17 sources

Virginia Politics · Virginia See the Story

Global Developments: AI Progress, Pharma Queries, and Tech Alliances

100% Center coverage: 1 sources

Global Developments: AI Progress, Pharma Queries, and Tech Alliances In a bid to challenge Western counterparts in AI processor production, China's Semiconductor Manufacturing International Corporation is reportedly testing an advanced DUV lithography machine developed by a Shanghai-based start-up.Meanwhile, in the UK, queries have arisen within the government about whether pharmaceutical companies, such as Eli Lilly, Merck, and AstraZeneca, are…BlackRock · Shanghai Read Article

News about Eli Lilly

News about Eli Lilly

Covered Most By

Local News Publishers

Top Eli Lilly News

Eli Lilly to invest $5 billion in new Virginia plant as pharma braces for tariffs

UK's GSK Announces $30 Billion U.S. Pharma Investment Amid Trump State Visit

Eli Lilly’s obesity pill outperforms Novo Nordisk’s oral drug in head-to-head diabetes trial

Jim Cramer says Eli Lilly's obesity pill could be more of a 'lifetime drug' than shots

Novo Nordisk Stock Is a Better Obesity Play Than Eli Lilly, Berenberg Says

Eli Lilly’s obesity pill outperforms Novo Nordisk’s oral drug in head-to-head diabetes trial

Berenberg Bank Reiterates "Hold" Rating for Eli Lilly and Company (NYSE:LLY)

Alchemab Therapeutics initiates Phase 1 clinical trial of ATLX-1282 and announces Series A financing extension

Lilly Weakens on Data Reveal for Oral Obesity Candidate

MassMutual Private Wealth & Trust FSB Purchases 376 Shares of Eli Lilly and Company $LLY

After Oprah Winfrey Special: Novo Nordisk Receives Us Warning

Eli Lilly to invest $5 billion in new Virginia plant as pharma braces for tariffs

Global Developments: AI Progress, Pharma Queries, and Tech Alliances

Covered Most By

Media Bias Breakdown

Breaking News Topics Related to Eli Lilly

Jim Cramer says Eli Lilly's obesity pill could be more of a 'lifetime drug' than shots

Novo Nordisk Stock Is a Better Obesity Play Than Eli Lilly, Berenberg Says

Eli Lilly’s obesity pill outperforms Novo Nordisk’s oral drug in head-to-head diabetes trial

Berenberg Bank Reiterates "Hold" Rating for Eli Lilly and Company (NYSE:LLY)

Alchemab Therapeutics initiates Phase 1 clinical trial of ATLX-1282 and announces Series A financing extension

Lilly Weakens on Data Reveal for Oral Obesity Candidate

MassMutual Private Wealth & Trust FSB Purchases 376 Shares of Eli Lilly and Company $LLY

After Oprah Winfrey Special: Novo Nordisk Receives Us Warning

Eli Lilly to invest $5 billion in new Virginia plant as pharma braces for tariffs

Global Developments: AI Progress, Pharma Queries, and Tech Alliances